Jean-philippe P. Metges
Brest, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Case Report: long complete metabolic response assessed by LAFOV FDG-PET/CT to FOLFIRINOX in first-line treatment of metastatic low-differentiated pancreatic carcinoma.
Journal: Frontiers in medicine
Published: January 15, 2026
First-line zolbetuximab plus mFOLFOX6 and nivolumab in unresectable CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial.
Journal: Nature medicine
Published: November 07, 2025
TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second-Line Treatment in Patients With Advanced Pancreatic Adenocarcinoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 04, 2025
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer.
Journal: The New England journal of medicine
Published: June 02, 2025
Perioperative red blood cell transfusion following high-risk oncologic surgery for tumor resection: a systematic review and meta-analysis.
Journal: Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine
Published: May 05, 2025
Bevacizumab-based chemotherapy adaptive to pharmacokinetic of bevacizumab in first-line treatment of patients with unresectable metastatic colorectal cancer: A double-blind, multicenter, randomized phase III trial study (PHARBEVACOL trial).
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: February 09, 2025
Comprehensive assessment of 1-year postoperative venous thromboembolism and associated mortality risks in hepatopancreatobiliary cancer surgeries: A national survey.
Journal: Surgery
Published: August 23, 2024
Devimistat (CPI-613) With Modified Fluorouarcil, Oxaliplatin, Irinotecan, and Leucovorin (FFX) Versus FFX for Patients With Metastatic Adenocarcinoma of the Pancreas: The Phase III AVENGER 500 Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 01, 2024
Dose to cardiac substructures and cardiovascular events in esophageal cancer patients treated with definitive radiotherapy.
Journal: Radiation oncology (London, England)
Published: July 17, 2024
Resection of colorectal liver metastases with second-line aflibercept plus FOLFIRI: Results from the RESECTION prospective French cohort.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 12, 2024
ASO Author Reflections: Surgical Threshold Reforms in Gastrointestinal Oncology in France: Balancing Surgical Volume, Quality of Care, and Access to Care.
Journal: Annals of surgical oncology
Published: February 14, 2024
Last Updated: 09/26/2026